Market revenue in 2021 | USD 4,019.5 billion |
Market revenue in 2028 | USD 14,820.7 billion |
Growth rate | 20.5% (CAGR from 2021 to 2028) |
Largest segment | Wearables |
Fastest growing segment | Smart Drugs |
Historical data covered | 2018 - 2020 |
Base year for estimation | 2021 |
Forecast period covered | 2022 - 2028 |
Quantitative units | Revenue in USD billion |
Market segmentation | Wearables, Implants (Chips), Gene Modification Kits, Smart Drugs, Supplements, Mobile Apps |
Key market players worldwide | Apple Inc, Fitbit, Harvey Norman Holdings Ltd, The ODIN, Thync, Moodmetric, Thriveport, TrackMyStack, OsteoStrong San Jose |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biohacking market will help companies and investors design strategic landscapes.
Wearables was the largest segment with a revenue share of 17.98% in 2021. Horizon Databook has segmented the Asia Pacific biohacking market based on wearables, implants (chips), gene modification kits, smart drugs, supplements, mobile apps covering the revenue growth of each sub-segment from 2018 to 2028.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific biohacking market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific biohacking market from 2018 to 2028, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account